Cargando…
Upregulation of CD3ζ and L‐selectin in antigen‐specific cytotoxic T lymphocytes by eliminating myeloid‐derived suppressor cells with doxorubicin to improve killing efficacy of neuroblastoma cells in vitro
BACKGROUND: Agglomeration of myeloid‐derived suppressor cells (MDSCs) in tumors impedes immunotherapeutic effects. Doxorubicin (DOX) is currently the most specific drug used for the selective removal of MDSCs. Here, we study the feasibility and mechanism of eliminating MDSCs by DOX to improve antige...
Autores principales: | Xu, Weili, Li, Suolin, Li, Meng, Zhou, Hui, Yang, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761462/ https://www.ncbi.nlm.nih.gov/pubmed/34861064 http://dx.doi.org/10.1002/jcla.24158 |
Ejemplares similares
-
Targeted inhibition of myeloid-derived suppressor cells in the tumor microenvironment by low-dose doxorubicin to improve immune efficacy in murine neuroblastoma
por: Xu, Wei-Li, et al.
Publicado: (2021) -
The comparison of cytotoxicity of the anticancer drugs doxorubicin and ellipticine to human neuroblastoma cells
por: Poljaková, Jitka, et al.
Publicado: (2008) -
Targeting P-selectin blocks neuroblastoma growth
por: Nolo, Riitta, et al.
Publicado: (2017) -
Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E- selectin expression in human squamous cell carcinomas
por: Gehad, Ahmed, et al.
Publicado: (2012) -
Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing PGE(2)
por: Rong, Yuan, et al.
Publicado: (2016)